The Economic Times Healthcare and Biotech News This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.

Sun Pharma revises upwards price to fully acquire Taro to USD 43 per share
In May this year, Sun Pharmaceutical Industries announced a non-binding indication of interest to acquire all of the outstanding ordinary shares of Taro for a purchase price of USD 38 per ordinary share in cash through a reverse triangular merger. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - December 12, 2023 Category: Pharmaceuticals Source Type: news

USFDA issues Form 483 with 5 procedural observations to Torrent Pharma's Gujarat unit
Torrent Pharmaceuticals said Tuesday that the US health regulator has given them a Form 483 with five procedural comments after inspecting their oral manufacturing facility in Gujarat, India. According to the US Food and Drug Administration (USFDA), Form 483 is given to a company's management after an inspection if the investigator notices any conditions that might break the rules under the Food Drug and Cosmetic (FD&C) Act and related Acts. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - December 12, 2023 Category: Pharmaceuticals Source Type: news

Cipla unit recalls one lot of medication in US due to seal integrity issue
Drug major Cipla's subsidiary is voluntarily recalling one lot of medication in the US due to seal integrity issues. InvaGen Pharmaceuticals Inc, USA, is voluntarily recalling one lot of Vigabatrin for Oral Solution, USP (500 mg), at the consumer level due to seal integrity issues, allowing for powder leakage from the pouch, the Mumbai-based drug maker said in a regulatory filing. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - December 10, 2023 Category: Pharmaceuticals Source Type: news

USFDA pulls up Intas Pharma for manufacturing lapses at Ahmedabad plant
In a warning letter to the company's CEO and MD Nimish Chudgar, the US Food and Drug Administration (USFDA) has pointed out various manufacturing lapses at the Matoda-Sanand, Ahmedabad-based facility. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - December 10, 2023 Category: Pharmaceuticals Source Type: news

Masks are still being worn by some individuals—but not for health reasons
A remnant of the Covid-19 era, masks are being worn by some individuals not only for health reasons but also for the sake of privacy. The demand for masks has dropped significantly after Covid. A Statista Consumer Market Insights report reveals that in 2021, about 402 billion masks were sold worldwide, compared with an estimated 23 billion in 2023. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - December 9, 2023 Category: Pharmaceuticals Source Type: news